Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schnorr

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Der Urologe. Ausg. A|September 17, 1998
[Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma]M Lein, L Nowak, K Jung, et al.
Radiobiologia, Radiotherapia|June 1, 1979
[2 years of experience with 89Sr therapy of multiple bone metastases (author's transl)]H J Correns, E Mitterlechner, K Buchali, et al.
European Journal of Nuclear Medicine|February 1, 1979
89Strontium therapy of bone metastases of carcinoma of the prostatic glandH J Correns, M Mebel, K Buchali, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 1, 2000
[The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging]D Beyersdorff, M Taupitz, M Giessing, et al.
Der Radiologe|August 9, 2005
[Utilizing optical coherence tomography (OCT) for visualization of urothelial diseases of the urinary bladder]D Daniltchenko, F König, E Lankenau, et al.
Clinical Chemistry|March 25, 1998
Preanalytical determinants of total and free prostate-specific antigen and their ratio: blood collection and storage conditionsK Jung, P von Klinggräff, B Brux, et al.
Zentralblatt Fur Chirurgie|January 1, 1979
[Diagnostics and therapy of the carcinoma of the prostate (author's transl)]D Schnorr, H M Guddat, D Neuser, et al.
Der Urologe. Ausg. A|April 3, 2003
[Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)]F Richter, M E Tüllmann, I Türk, et al.
The Prostate|March 10, 2001
Receiver-operating characteristic as a tool for evaluating the diagnostic performance of prostate-specific antigen and its molecular forms--What has to be considered?K Jung, C Stephan, M Lein, et al.
Clinical Chemistry and Laboratory Medicine|August 6, 2000
Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomyC Stephan, K Jung, B Brux, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Der Urologe. Ausg. A|September 17, 1998
[Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma]M Lein, L Nowak, K Jung, et al.
Radiobiologia, Radiotherapia|June 1, 1979
[2 years of experience with 89Sr therapy of multiple bone metastases (author's transl)]H J Correns, E Mitterlechner, K Buchali, et al.
European Journal of Nuclear Medicine|February 1, 1979
89Strontium therapy of bone metastases of carcinoma of the prostatic glandH J Correns, M Mebel, K Buchali, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 1, 2000
[The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging]D Beyersdorff, M Taupitz, M Giessing, et al.
Der Radiologe|August 9, 2005
[Utilizing optical coherence tomography (OCT) for visualization of urothelial diseases of the urinary bladder]D Daniltchenko, F König, E Lankenau, et al.
Clinical Chemistry|March 25, 1998
Preanalytical determinants of total and free prostate-specific antigen and their ratio: blood collection and storage conditionsK Jung, P von Klinggräff, B Brux, et al.
Zentralblatt Fur Chirurgie|January 1, 1979
[Diagnostics and therapy of the carcinoma of the prostate (author's transl)]D Schnorr, H M Guddat, D Neuser, et al.
Der Urologe. Ausg. A|April 3, 2003
[Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)]F Richter, M E Tüllmann, I Türk, et al.
The Prostate|March 10, 2001
Receiver-operating characteristic as a tool for evaluating the diagnostic performance of prostate-specific antigen and its molecular forms--What has to be considered?K Jung, C Stephan, M Lein, et al.
Clinical Chemistry and Laboratory Medicine|August 6, 2000
Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomyC Stephan, K Jung, B Brux, et al.
Pageof 12